Difference between revisions of "Team:Birkbeck"

Line 42: Line 42:
  
  
−
<p>THANKYOU SEAN</p>
+
<!--<p>THANKYOU SEAN</p>
  
 
<p>TEAM - This section of our website lets you know more about our team members and those outside the team, including our sponsors, without whom our project would never have been completed.</p>
 
<p>TEAM - This section of our website lets you know more about our team members and those outside the team, including our sponsors, without whom our project would never have been completed.</p>
Line 48: Line 48:
 
<p>RESEARCH - This section of our website lets you know important details about our project, like why did we choose it, what have we accomplished in the lab, and how have we ensured it is done safely.</p>
 
<p>RESEARCH - This section of our website lets you know important details about our project, like why did we choose it, what have we accomplished in the lab, and how have we ensured it is done safely.</p>
  
−
<p>ETC.</p>
+
<p>ETC.</p>-->
 
<!--#################################################################UPDATE NEEDED
 
<!--#################################################################UPDATE NEEDED
  

Revision as of 02:06, 19 September 2015

iGEM Westminster Logo




Birkbeck iGEM

The Owligos are the first-ever team entered into the international Genetically Engineered Machine (iGEM) Competition by Birkbeck, University of London. We’re a varied group of students who reflect the diversity and unique character of our institution: many of us have chosen science as a second career, having already spent some time in full-time work. For most of us, this has meant making our way through a degree while continuing to work full-time. Hopefully this kind of dedication will help us successfully navigate our way through our iGEM project.

Project Aim

Our project aims to create a new diagnostic solution that will be low-tech and cost-effective enough to allow its usage in deprived and remote communities. We’re attempting to engineer a bacteriophage lambda chassis to change its host affinity, while simultaneously adding a marker that will facilitate easy detection of a target bacterial pathogen in patient samples.

To demonstrate this approach as a proof of concept for the competition, we plan to change this affinity between different strains of E.coli; however, ultimately we hope to demonstrate that this principle could also be applied to alter the phage’s host range to other bacterial species. We could then provide a modular system capable of diagnosing a range of diseases. Of course, we haven’t chosen a simple goal. But as Birkbeck pioneers, we are determined to prove ourselves by making our project a success. We can’t wait to present the results of our work at the Giant Jamboree in September!